Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ozaki MK"'
Autor:
Bernhardt SM; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA., Ozaki MK; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA., Betts C; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA., Bleyle LA; Bioanalytical Shared Resource/Pharmacokinetics Core Facility, University Shared Resources, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA., DeBarber AE; Bioanalytical Shared Resource/Pharmacokinetics Core Facility, University Shared Resources, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA., Fornetti J; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, 84112, USA., Liberty AL; Division of Complex Family Planning, Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, OR, 97239, USA., Wilde De E; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA., Zhang Y; Computational Biology Program, Oregon Health & Science University, Portland, OR 97201, USA., Xia Z; Computational Biology Program, Oregon Health & Science University, Portland, OR 97201, USA., Schedin P; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Jun 02. Date of Electronic Publication: 2024 Jun 02.
Autor:
Jindal S; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Pennock ND; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA., Sun D; Computational Biology Program, Oregon Health & Science University, Portland, OR, USA., Horton W; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA.; Computational Biology Program, Oregon Health & Science University, Portland, OR, USA., Ozaki MK; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA., Narasimhan J; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA., Bartlett AQ; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA., Weinmann S; Center for Health Research, Kaiser Permanente Northwest, 3800N. Interstate Ave., Portland, OR, USA., Goss PE; Massachusetts General Hospital Cancer Center, Harvard University, Boston, MA, USA., Borges VF; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Young Women's Breast Cancer Translational Program, University of Colorado Cancer Center, Aurora, CO, USA., Xia Z; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Computational Biology Program, Oregon Health & Science University, Portland, OR, USA.; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA., Schedin P; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA. schedin@ohsu.edu.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. schedin@ohsu.edu.; Young Women's Breast Cancer Translational Program, University of Colorado Cancer Center, Aurora, CO, USA. schedin@ohsu.edu.
Publikováno v:
Nature communications [Nat Commun] 2021 Nov 03; Vol. 12 (1), pp. 6341. Date of Electronic Publication: 2021 Nov 03.
Autor:
Harrington BS; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Ozaki MK; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Caminear MW; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Hernandez LF; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Jordan E; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Kalinowski NJ; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Goldlust IS; The National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA., Guha R; The National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA., Ferrer M; The National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA., Thomas C; The National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA., Shetty J; CCR Sequencing Facility, Leidos Biomedical Research, Inc., FNLCR, Frederick, MD 21701 , USA., Tran B; CCR Sequencing Facility, Leidos Biomedical Research, Inc., FNLCR, Frederick, MD 21701 , USA., Wong N; CCR Collaborative Bioinformatics Resource, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA., House CD; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Annunziata CM; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Jun 21; Vol. 12 (6). Date of Electronic Publication: 2020 Jun 21.
Autor:
Weiss JM; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute (NCI) at Frederick, Frederick, Maryland, USA., Davies LC; Cardiff University, Division of Infection and Immunity, Cardiff, United Kingdom., Karwan M; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, Maryland, USA., Ileva L; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, Maryland, USA., Ozaki MK; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland, USA., Cheng RY; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute (NCI) at Frederick, Frederick, Maryland, USA., Ridnour LA; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute (NCI) at Frederick, Frederick, Maryland, USA., Annunziata CM; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland, USA., Wink DA; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute (NCI) at Frederick, Frederick, Maryland, USA., McVicar DW; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute (NCI) at Frederick, Frederick, Maryland, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2018 Aug 31; Vol. 128 (9), pp. 3794-3805. Date of Electronic Publication: 2018 Jul 30.